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Please note: Reviewer comments are italics with authors’ response in standard font. 
Corresponding page numbers are applicable to the revised manuscript with all track changed 
accepted.  
 
Reviewer 1 comments 
 
Abstract 
Suggest clarify that the study was restricted to influenza seasons, and describe the setting were 
children were seen and samples collected.  
Response 
Information on the restrictions on enrolment, study setting and samples collected were amended in 
the abstract (p.5).  
 
Please double check calculations as some appear to be a little off – this may be due to some rounding 
or observations with missing values but this is not clear in the results section (see additional 
comments below).  
Response 
As the reviewer has suggested, the differences in the presented results in the Abstract were due to 
rounding. To minimise confusion, we have amended the abstract to report results up to 1 decimal 
place as appropriate (pp.5-6).  
 
The calculation of the predicted probabilities from the logistic regression model needs to be clearly 
described in the methods section. Whether the predicted probability for flu + RSV is significantly 
higher than others need to be clarified as well.  
Response 
We have clarified this in the abstract of the revised manuscript (pp.5-6).  
 
Introduction 
Suggest reconcile description of study settings with information from methods, as apparently not all 
recruitments were done at the emergency department 
Response 
To simplify analyses and minimise confusion regarding the study setting, we have chosen to exclude 
children enrolled from general practises in the revised manuscript. Only 131 were recruited from 
general practice in 2008-2009 before this arm of the study was stopped. All children included in the 
analyses were enrolled while they were transiting through the emergency department. A portion of 
these children would subsequently have been admitted as inpatients. We have included additional 
information on the timing and location of enrolment in the Introduction (p.7) with further 
information included in the Methods section (p.8). The number of patients excluded from general 
practice are included in the Results section (p.12). 
 
Methods 
Settings and participants 
Suggest clarify how the influenza seasons were defined, based on calendar week/month?, laboratory 
surveillance?, etc. 
Response 
The start and end of influenza seasons were defined by the Infectious Diseases Surveillance Unit at 
PathWest Laboratory Medicine WA using a combination of indicators, including weekly proportion of 
laboratory influenza tests positive. As a guide, two consecutive weeks with over 10% influenza test 
positive often coincides with the beginning of influenza season in WA. The manuscript has been 
amended to include additional information on how influenza seasons were defined (p.8).   
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Clarify the different settings that were used for enrolment by season, and describe the distribution of 
these patients in results (e.g. % of children enrolled from inpatient facilities, etc.). How were 
hospitalized children treated in the analysis, for example in the assessment of risk of hospitalization? 
Response 
We acknowledge the confusion in the distribution of enrolment settings and consequently have 
opted to exclude data from all children enrolled at general practises (see response to Introduction 
comments above). All children presented to the emergency department of a single hospital and 
were either admitted or discharged home. Hospital admission was a key outcome of interest.  
 
How was influenza vaccination data collected? What proportion of self-report was verified? What 
proportion of children were fully vaccinated?  
Response 
Vaccination data were collected through parental-report and confirmed through the Australian 
Childhood Immunisation Register. If there was ongoing uncertainty, immunisation providers were 
contacted. Data on vaccination status (apart from influenza vaccination) were not collected. The 
manuscript has been amended to include this information (p.9). 
 
Was antiviral use before sample collection measured or accounted for in the analyses? 
Response 
Only data on antiviral use post-enrolment were collected as part of the follow-up questionnaire. 
However, only 9 patients were prescribed anti-viral medications and as such, data on anti-viral 
medications were not included in the analyses.  
 
Respiratory virus detection 
Several tests are described for different viruses but it is unclear if testing was systematic throughout 
the study period or some changes in testing were implemented over time. This seems very crucial as 
not all the described tests may have similar performance for viral detections. This information needs 
to be clearly described in the methods section. 
Response 
Testing was consistent throughout the study with all patients undergoing the same panel of tests 
with the only exception being testing for human metapneumovirus (hMPV). References detailing the 
PCR assays designed and validated specifically for this study have been included in the manuscript 
(reference #14-16). Testing for hMPV was based on clinical need. In addition, during the lifetime of 
the study, a PCR assay for hMPV was designed and implemented, gradually replacing the previously 
utilised antigen detection assay. Although infrequently detected, we have elected to include samples 
using both hMPV assays given the importance of this pathogen. This information has been included 
in the Methods section (p.10) and we have also acknowledged the limitations of using two assays in 
the Discussion section (p. 16).  
 
Also, please clarify if all samples were tested for all study viruses – this is important to confirm that 
samples had equal chance of having co-detections identified.  
Response 
All samples were tested for all study viruses (see response above). 
 
Was influenza and parainfluenza combined for all analyses? Suggest clarify the rationale for this 
decision – if this is the case then the abstract, discussion and conclusions need to be revised 
accordingly. 
Response 
Influenza virus subtypes (i.e. Influenza A, B and C) were grouped together. Likewise, subtypes of 
parainfluenza (i.e. parainfluenza types 1-4) were grouped together. Influenza and parainfluenza 
were treated as separate groups. This point has been clarified in the Methods section (p. 10).  
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Definitions and statistical analysis 
Clarify how the children enrolled in the inpatient setting were considered for the study of 
hospitalization as an outcome.  
Response 
As all children transited through the emergency department, all children were treated in the same 
manner in the regression model with hospitalisation as the outcome measure.  
 
How was age (covariate) accounted for in the regression models? The table shows data as a 
categorical variable but use of age as a continuous variable is warranted to minimize residual 
confounding.  
Response 
In the original manuscript, age was included in the model as a categorical variable with 5 subgroups 
(i.e. 6-11 months, 12-23 months, 2 years, 3 years and 4 years). We have since re-assessed models 
that include age as a continuous variable and found no difference in the model fit whether age was 
used as a continuous or categorical variable. As such, we have chosen to retain age as a categorical 
variable for the easier interpretation of the results. We have amended the manuscript to explicitly 
state this in Method sections (p.11) and as footnotes in Table 2.  
 
Suggest clarify the models were used to calculate ‘predicted’ probabilities – it is important to provide 
details about model building strategies, as the estimated probabilities depend heavily on the model 
structure. Suggest consider influenza vaccination history before enrolment, antiviral use, duration of 
disease (from onset to testing), enrolment setting and respiratory season as additional covariates for 
the regression models. If additional information is available about presence of young children at 
home, that would be another covariate of interest.  
Response 
We acknowledge that the addition of the suggested covariates would help to strengthen the models. 
We have attempted to include these additional covariates into the models but found that this 
greatly reduces the number of cases contributing data to the model due to missing data. 
Comparisons, using the likelihood ratio test of standardised sample size, of the logistic regression 
model of hospitalisation with all the additional covariates requested showed no significant 
differences in model fit compared to the restricted model with only the covariates listed in the 
original manuscript. Inclusion of all requested covariates also resulted in quasi-separation of the 
data, which limited our ability to perform the post-hoc analyses used to produce Figures 2 and 3.  
 
As such, we have decided to retain the covariates used in the original model. We have also included 
additional information on the model building strategies used in the Methods section of the revised 
manuscript (p.11).  
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Results 
How many seasons were included in the study? Was the pandemic year distinct enough, so that it 
may warrant a sensitivity analysis excluding it from the main analysis? 
Response 
Influenza seasons from 2008 to 2012 (i.e. total of 5 influenza seasons) were included in this analyses. 
Given the questionable impact of co-detection is relevant in both pandemic and seasonal influenza 
seasons, we have kept the 2009 season in the analysis. While we acknowledge that it would be 
interesting to perform a sensitivity analyses excluding data from the pandemic year (2009), we feel 
that this would be outside the scope of this study. Furthermore, excluding data from this year would 
likely limit our ability to assess the effects of specific virus pairs given the limited sample size.  
 
Clarify what proportion of children had comorbidities. 
Response 
The manuscript has been amended to include this information (p.11).  
 
Suggest clarify whether the described antibiotic use refers to the enrollment event or the follow-up 
questionnaire?  
Response 
Data on antibiotic use was collected in the follow-up questionnaire. We have amended the 
manuscript to explicitly state that it refers to antibiotic use post-enrolment (p.12). 
 
How many children had completed the follow-up questionnaire? It seems that the outcomes would 
be only known for those who completed it but cannot tell from the description. The proportion 
described with antibiotic data (52.6%) is very different from the proportion with hospitalization data 
(99%). The methods indicate that medical records review were done for hospitalizations but it is 
unclear whether antibiotic information was reviewed as well. This is very important as this 
potentially modify the n for some of the analyses.  
Response 
Of 2356 patients, 52.8% (n=1244) completed questions relating to outcomes (e.g. antibiotics use). 
Information on antibiotics data were not reviewed beyond data collected via questionnaire as the 
majority of patients were discharged from the emergency department and therefore, may not have 
adequate information recorded on subsequent antibiotic use. This information has been included in 
the Methods (p.9) and Results sections (p.12) of the amended manuscript.  
 
Please double check the odds ratio calculations, for example in table 2 it seems that the crude odds 
ratio for cough should be 1.8? Currently shown as 2.01 – similar concern for next row [rhinorrhea], 
this might be a rounding issue but please verify. If there were children missing information in some of 
the variables listed in the table, it would be useful to clarify that as well. Suggest add variables 
included for adjustment in a footnote for Table 2.  
Response 
The discrepancies were due to cases with missing data counted as not having a particular symptom 
or outcome, as the reviewer suggested. To clarify this, we have included the number of children with 
missing data for each of the symptoms and outcomes as a note in Table 2. The variables included in 
the adjusted models have been noted in the footnotes. Please note that the values presented in the 
revised manuscript may differ from the original manuscript due to the exclusion of children recruited 
from general practises.  
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Although predicted probabilities are shown in figures 2 and 3, these come from the regression 
models and it is unclear whether the described comparisons indicated significant differences or 
whether chance could not be ruled out – this needs to be clarified carefully, and description of results 
and discussion revised accordingly, if necessary.  
Response 
We have amended the Methods (p.11), Results (pp.13-14) and Discussion sections (p.14) concerning 
these results to clarify this point. Figures 2 and 3 also include 95% confidence intervals to minimise 
the risk of over-interpretation.  
 
Besides the described symptoms, it would helpful to show the distribution of actual medical 
diagnoses that these children received. For example were co-detections more often seen in children 
with diagnosis of otitis media or pneumonia? I think this is a very important part and needs to be 
added to the report.  
Response 
We acknowledge that discharge diagnosis would have added to the analyses presented in this 
manuscript. Unfortunately, data on the diagnoses received at discharge were not collected for this 
study. This point has been added as a potential limitation of this study in the Discussion section of 
the manuscript (p. 16).  
 
Also, children may present with more than 1 symptom, but it is not clear how those were treated in 
the analyses, please clarify. 
Response 
We have interpreted this comment to mean that the reviewer is concerned about counting the same 
person contributing more than 1 data point in a model (i.e. if they had more than 1 symptom). As 
each symptom and outcome was treated as a separate model, the same child could present with 
more than 1 symptoms but will only be counted once in a particular model.  
 
Discussion 
Suggest clarify if described predicted probabilities were significantly higher than other groups to 
support statement in first paragraph.  
Response 
The predicted probability of hospitalisation for those with influenza and RSV co-detections were 
higher compared to those with influenza virus infection only with a trend observed compared with 
RSV virus infection only. To avoid confusion, we have clarified this point in the first paragraph of the 
Discussion section (p.14).  
 
The description of the post-hoc power calculation is very confusing, what is the difference of interest 
for the calculation? Since the sample size is already fixed (this is a retrospective assessment), I am not 
sure how useful a power estimate is – the lack of precision can be appreciated directly by the width of 
the estimated confidence intervals. Suggest delete the power calculation description.  
Response 
The power calculations were provided to suggest the numbers required to detect differences 
between influenza and rhinovirus should a reader wish to do so in a future study. We acknowledge 
that this can be confusing and have deleted this description from the Discussion.  
 
MPV detections were the lowest of all detections. How does the MPV % detections compare to other 
studies? Please discuss potential reasons for discrepancies.  
Response 
hMPV detections in this cohort was 1.0% (26/2487), which is lower than those shown in other 
studies (approximately 5-13% for this age group). This could be partly due to lower sensitivity of 
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immunofluorescence in comparison to PCR when detecting hMPV. This information has been 
included in the Discussion section of the revised manuscript (p.16).   
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Reviewer 2 comments 
In general, I would dissuade the frequent use of “co-infection” and favor “co-detection,” since this is 
largely a description of molecular detection of viruses and many of the positives (such as for 
rhinoviruses, in particular) may represent detection of viruses that reflect prolonged shedding in the 
nasopharynx but not current active infection.  “Coinfection” is defined in the introduction, but I would 
still recommend that the authors use “co-detection” more frequently when describing results and 
conclusions.   
Response 
We acknowledge that we cannot distinguish between active infection and viral shedding and have 
changed the term “coinfection” to “co-detection” in the manuscript. We would refrain from using 
both terms within the same manuscript so as to not confuse the reader. We have also added further 
comments acknowledging the role of viral shedding in the Discussion section of the manuscript 
(p.16). 
 
The abstract notes that rhinovirus (40%), influenza (29%), and RSV (27%) were the most commonly 
detected viruses.  Please also present these percentages in the Results section and be clear that these 
are out of the 1728 with a virus detected (not of the 2487 eligible patients). 
Response 
Both the abstract (p.5) and Results section (p.16) has been amended to include this information.  
 
The abstract notes that nasal swabs were tested, but the Methods section says a nasopharyngeal 
swab or aspirate was collected at enrollment.  Please be specific as to what was routinely collected – 
was it nasal swab or aspirate?  Was specimen type collected at clinician discretion?  Were the swabs 
anterior nasal, mid-turbinate, or nasopharyngeal? 
Response 
Bilateral mid-turbinate nasal swabs (Copan Diagnostics, Murrieta, CA) placed into viral transport was 
the preferred specimen however if a nasopharyngeal aspirate (NPA) had already been performed, 
this sample was used rather than repeating the diagnostic test. 84.9% of samples collected were 
nasal swabs with the remainder NPA. This information has been added in the Methods section of the 
revised manuscript (p.9).  
 
How much was added with the use of viral culture? I am not sure if there is room for this information 
to be included, but it would be interesting to know if testing by culture added to the virus detections.  
It is also worth noting that the number of hMPV positives seems very low relative to the other viruses 
– which causes one to question the sensitivity of the multiplex PCR and immunofluorescent assay for 
detection of hMPV.  Please comment in the manuscript on this. 
Response 
Of 1630 patients with viruses detected, 34 patients (2.1%) had a virus detected only through culture. 
We have not included this information in the manuscript as it is not central to the main aims of this 
study.  
 
We acknowledge that the proportion of children testing positive for hMPV in this cohort were lower 
than that in other studies and have included it as a point of Discussion (p.16) in the revised 
manuscript.  
 
Line 55-56 on page 11 to top of page 12:  Would note that children with co-detection of viruses were 
significantly younger compared with children with single virus detection; and while it is true that the 
percentage in out-of-home care was highest in the co-detection group, it was not statistically higher 
(as the confidence intervals overlap).  
Response 
We have amended the manuscript clarify these points in the Results (p.13).  
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Was there any information available regarding use of antivirals for treatment of influenza?  It would 
be informative to include this information in the results, if available, and if there is sufficient space.   
Response 
Although data on antiviral use were collected from the follow-up questionnaire, we were unable to 
assess the role of antivirals in this study as only 9 patients were prescribed them (data not shown).  
 
Because this was a study which required ILI for enrollment, all patients had fever as part of the case 
definition. This is well noted in the Discussion as a limitation, but would also recommend clarification 
in the Conclusions of the Abstract and throughout the Discussion that “Overall, coinfection has 
limited impact on clinical severity among young children with ILI.”  This should be clearer, for 
example, in the first and last paragraphs of the Discussion. 
Response 
We acknowledge that this is a valid point and have amended the abstract (p.6) and Discussion 
section (p.14, 16) in the revised manuscript to explicitly state this.   
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Abstract 
Background 
Children with acute respiratory tract infection (ARTI) frequently exhibit viral-viral co-
detection, yet its clinical significance remains contentious. Using data from a 
prospective cohort of children with influenza-like illness, we described the virology of 
ARTI and determined the clinical impact of viral-viral co-detection. 
 
Methods 
Children aged 6-59 months presenting to a tertiary paediatric hospital with fever and 
acute respiratory symptoms were enrolled and nasal samples collected during 
influenza seasons in 2008-2012. Respiratory viruses were identified by culture and 
PCR. We compared demographics, presenting symptoms and clinical outcomes of 
children with single viral infection and viral-viral co-detection. We used logistic 
regression models and estimated marginal means to calculate the adjusted odds 
ratio and probabilities of symptom presentation, antibiotic prescription or 
hospitalisation.  
 
Results 
1630 of 2356 children (69.2%) had a virus detected, among whom rhinovirus 
(40.8%), influenza (29.5%) and respiratory syncytial virus (RSV; 26.4%) were most 
commonly detected. 24% of these had two or more viruses detected. After adjusting 
for demographic factors, children with co-detection had greater odds of presenting 
with cough (aOR=1.9, 95% CI:1.2-3.1), rhinorrhoea (aOR=1.8, 95% CI:1.1-2.9) than 
those with single infection, although both symptoms were common. Children with 
influenza and RSV combined had the highest probability of hospitalisation 
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(probability=55%, 95%CI:35-73%), significantly greater than those with influenza 
infection alone (probability=22%, 95%CI:16-29%).  
 
Conclusions 
Overall, co-detection has limited impact on clinical severity among children with 
influenza-like illness. However, specific pathogen pairs may be associated with more 
severe outcomes. Routine diagnostics to identify viral co-detection should be 
restricted to common pathogens. 
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1 Introduction 
Acute respiratory tract infections (ARTI) in children place a significant burden on 
families and the community. Commonly recognized respiratory viral pathogens 
include influenza viruses, respiratory syncytial viruses (RSV), parainfluenza viruses, 
human rhinoviruses, adenoviruses and coronaviruses [1,2]. Advances in laboratory 
diagnostic techniques have resulted in the discovery of new viruses, including 
human metapneumovirus (hMPV) and polyomaviruses [3,4], yet a number of these 
pathogens have uncertain pathogenicity [5,6].  
 
Co-detection can be defined as detection of two or more pathogens in a single 
sample. With the improved sensitivity, availability and affordability of modern 
diagnostics, viral-viral co-detections are being increasingly identified. The incidence 
of viral-viral co-detection has been reported between 15-45%, depending on age, 
location and testing methods [7–9]. The clinical significance of co-detection in ARTI 
remains contentious with the literature ranging from negligible to deleterious effects 
[9,10]. 
 
This study describes the virology of ARTI in children aged six months to four years 
who presented with influenza-like illness during influenza season to a tertiary 
paediatric hospital in Australia. This study also enabled us to specifically examine 
the impact of viral-viral co-detection on clinical symptoms and outcomes. 
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2 Materials and Methods 
2.1 Study setting and patients 
Western Australia (WA) spans 2.5 million square kilometres with a population of 
approximately 2.5 million people, 7% of whom are under 5 years of age [11]. 
Princess Margaret Hospital for Children (PMH) is the only tertiary paediatric hospital 
in the state and is located in metropolitan Perth where approximately 80% of the 
population resides [12]. 
 
Commencing in 2008, the Western Australia Influenza Vaccine Effectiveness 
(WAIVE) Study was an observational cohort study established to determine the 
effectiveness of inactivated influenza vaccine. Patient recruitment was conducted at 
PMH (and at selected general practises in metropolitan WA in 2008-2009). Due to 
small numbers recruited and differences in presentation, data from children 
presenting to general practises were removed from these analyses.  
 
Patient recruitment coincided with the annual influenza seasons. The start and end 
of influenza seasons were defined by the Infectious Diseases Surveillance Unit at 
PathWest Laboratory Medicine WA using a combination of indicators, including 
weekly proportion of laboratory influenza tests positive. As a guide, two consecutive 
weeks with over 10% influenza test positive often coincides with the beginning of 
influenza season in WA. Further details on study design are described elsewhere 
[13].  
 
All children 6-59 months of age presenting to PMH with a history of fever (by 
parental report) or with a measured temperature of greater than 37.5°C at 
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9 
presentation, accompanied by at least one acute respiratory symptoms within the 
previous 96 hours, were eligible for enrolment. All children transited through PMH 
emergency department. A portion of these children were subsequently admitted to 
hospital with the remainder discharged home from the emergency department. 
Children with a known immunodeficiency disorder, current or recent 
immunosuppressive treatment, or who received immunoglobulin in the previous 
three months were excluded from the study.  
 
Patient demographics, medical history and presenting symptoms were collected by 
parental questionnaire. Comorbidities recorded included prematurity, asthma, 
chronic cardiac, neurological or respiratory conditions. Influenza vaccination status 
was obtained by parental report and confirmed through the Australian Childhood 
Immunisation Register or by contacting immunisation providers. Vaccination status 
for other vaccines were not collected. A follow-up questionnaire of illness outcomes, 
including details of hospital admission(s), use of antibiotics and time to recovery, was 
provided to families to complete within 7-10 days after enrolment. A retrospective 
review of medical records was undertaken when hospitalisation data were incorrectly 
recorded or missing. No follow-up was conducted for antibiotics use if data were 
missing.  
 
2.2 Respiratory virus detection 
Children had bilateral mid-turbinate nasal swabs collected at enrolment (Copan 
Diagnostics Inc., Murrieta, CA). If a nasopharyngeal aspirate had already been 
collected by hospital staff as part of clinical care, this sample was used in lieu of a 
nasal swab. Viral culture (Madin-Darby Canine Kidney cells, Diploid lung fibroblasts) 
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and multiplex tandem PCR was used to detect all viruses except picornaviruses and 
hMPV [14,15]. Picornaviruses were detected using nested PCR [16] targeting the 
5’UTR of the picornavirus genome with sequencing used to assist with identification 
of rhinoviruses and enteroviruses. hMPV was tested using an immunofluorescent 
assay (Simulfluor hMPV Immunofluoresent Assay; Millipore, Temecula, CA) and 
PCR. All patients were subjected to the same panel of tests and testing methods 
were consistent throughout the study period with the exception of testing for hMPV; 
testing for hMPV was based on clinical need. While both immunofluorescence and 
PCR assays were used throughout the study period, PCR testing was more common 
in later years. 
 
For all viruses (except hMPV), positive viral detection was defined as detection by 
viral culture and/or PCR. Positive detection of hMPV was defined as detection by 
immunofluorescence and/or PCR. All influenza types/subtypes (i.e. influenza 
A/H1N1, A/H3N2 and B) were grouped for analysis. Similarly, subgroups of 
parainfluenza viruses (i.e. parainfluenza types 1-4) were grouped together for 
analysis. Infection was defined as detection of one or more of rhinovirus, influenza, 
RSV, parainfluenza, adenovirus, coronavirus or hMPV. Co-detection was defined as 
detection of two or more viruses in a single diagnostic sample.  
 
2.3 Definitions and statistical analysis 
Prematurity was defined as less than 37 weeks of gestation at birth. Out-of-home 
care was defined as attendance at playgroup, mothers’ group, day-care centre, 
kindergarten or preschool. Length of stay in hospital refers to the duration from 
admission to discharge date. Symptoms investigated included cough, rhinorrhoea, 
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11 
wheeze, dyspnoea, rash, diarrhoea and vomiting while outcomes investigated were 
antibiotic prescription and hospital admission. 
 
Data cleaning and analyses were performed in Microsoft Excel, EpiBasic [17] and 
SPSS version 23 (SPSS Inc., Chicago, IL). Categorical variables were compared 
using Pearson’s chi-squared tests. Logistic regression models were used to 
calculate odds ratios (OR) with 95% confidence intervals (CI) to compare those with 
single infection to those with co-detection. Dependent variables were symptom (e.g. 
presence of cough or rhinorrhoea) and outcome variables (e.g. hospitalisation or use 
of antibiotics). 
 
We calculated adjusted ORs (aORs) by including the following covariates in the 
logistic regression models: age, gender, Aboriginal status, prematurity, presence of 
comorbidities, out-of-home care and household smoking. Age was included as a 
categorical variable in the models and were divided into 6-11 months, 12-23 months, 
2 years, 3 years and 4 years (reference group). Covariates were selected based on 
known epidemiological or clinical risk factors for co-detection. Data from all patients 
were included in the adjusted models unless they had missing data on one or more 
covariates. To investigate the impact of specific pathogen pairs, analyses were 
repeated for the most common pathogen pairs. Estimated marginal means of logistic 
regression models were used to calculate probabilities with 95% CIs for antibiotic 
prescribing and hospitalisation for common pathogen pairs.  
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2.4 Ethical approvals 
This study was approved by the PMH Human Research Ethics Committee 
(1673/EP), the Western Australian Aboriginal Health Ethics Committee (212 06/08) 
and the University of Western Australia Research Ethics Committee (RA/4/1/6456).  
 
3 Results 
Of 2715 patients recruited from 2008 to 2012, data for 2356 patients were available 
for analysis. Reasons for exclusion included incorrect or unknown age (n=154, 
42.9% of all excluded patients), recruitment from general practice in 2008-2009 
(n=131, 36.5%) , incomplete pathogen testing (n=29, 8.1%), unknown vaccination 
history (n=7, 1.9%), incomplete data (n=12, 3.3%), multiple enrolments for the same 
episode of illness (n=3, 0.8%),  withdrawal from the study (n=23, 6.4%).  
 
Of the 2356 patients enrolled, the majority (n=1848, 78.4%) were enrolled while 
presenting to PMH emergency department. Of these 6.3% (n=117) were 
subsequently admitted to hospital. The median age was 22.0 months (interquartile 
range=14.0-35.0), 54.9% were male and 5.7% were of Aboriginal or Torres Strait 
Islander decent. Children born preterm accounted for 13.5% (n=319) of patients. 
Children with comorbidities accounted for 15.1% (n=355) of this cohort. Of those that 
had one or more comorbidity, asthma (n=218, 61.4%) and other chronic respiratory 
conditions (n=54, 15.2%) were most common. 
 
Of 2356 patients, 52.8% (n=1244) completed questions relating to outcomes (e.g. 
antibiotics use). Although parents were requested to complete these questions 7-10 
days post-enrolment, yet the mean time to completion was 19.3 days and ranged 
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13 
from 0 to 149 days (median=10 days). Data on antibiotic prescription post-enrolment 
were available for 51.0% (n=1201) of patients, of whom 483 (40.2%) were 
prescribed antibiotics. Combining data from questionnaires and review of hospital 
records resulted in near-complete data on hospitalisation (99.4%, n=2341), of whom 
610 (26.1%) were hospitalized. Of those who were admitted to hospital, the median 
length of stay was 2 days (interquartile range=1-3).  
 
Overall, 1630 patients (69.2%) tested positive for a virus. Of those with at least one 
virus detected, the most common were rhinovirus (n=665, 40.8%), influenza (n=481, 
29.5%) and RSV (n=431, 26.4%; Figure 1). Of those with a virus detected, 24.8% 
(n=404) had at least one other virus co-detected. Of these, 350 (86.6%) had 2 
viruses detected, 52 (12.9%) had 3 viruses detected and the remainder with 4 or 
more viruses.  
 
A greater proportion of children with multiple viruses detected were less than 2 years 
old (65.4%) compared to those with a single virus infection (51.2%, p<0.001; Table 
1). Those with co-detection also had greater odds of presenting with cough and 
rhinorrhoea compared to those with single infection, although both symptoms were 
common in both groups (Table 2). This effect remained after adjusting for other 
covariates. Of note, although less common, diarrhoea was more frequently observed 
in children with viral co-detection. There were no significant differences in the odds 
of being prescribed antibiotics (aOR=1.1, 95%CI: 0.8,1.5) or hospitalised (aOR=1.1, 
95%CI: 0.8,1.4) between patients with single infection and co-detection (Table 2).  
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We then selected the three most common pathogens (rhinovirus, influenza and RSV) 
and investigated associations of specific pathogen pairs with antibiotic prescription 
and hospitalisation. After adjusting for other covariates, patients with both influenza 
and RSV detected had a 52% probability (95% CI:28%-76%) of being prescribed 
antibiotics with a trend towards more frequent prescription when compared with 
those with influenza or RSV infection alone (Figure 2). Similarly, the probability of 
being hospitalised was highest in those with influenza and RSV detected 
(probability=55%, 95% CI:35-73%); significantly greater when compared with those 
with influenza infection alone (probability=22%, 95%CI:16-29%; Figure 3) and with a 
trend observed compared with RSV infection alone (probability=43%, 95%CI:36-
51%). 
 
4 Discussion 
This is one of the largest, single-site prospective studies of children up to 4 years of 
age that specifically investigates the incidence of and clinical outcomes associated 
with viral-viral co-detection. Our findings demonstrate that although differences in 
demographics, risk factors and symptoms are identifiable, in general, viral-viral co-
detection is unlikely to be associated with more severe clinical illness among young 
children with influenza-like illness. Specific pathogen pairs may be associated with 
an increased probability of hospitalisation as was observed with influenza and RSV. 
This finding has implications in paediatric healthcare facilities where isolation of all 
children with acute respiratory viral infection is difficult during periods of peak 
respiratory virus activity and cohorting of children is frequently required prior to the 
availability of diagnostic test results.  
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We detected small differences in the symptoms presented by patients with single 
infection compared to those with co-detection. However, these symptoms were 
common and therefore, likely to be of little clinical relevance. On the other hand, the 
clinical outcomes chosen (i.e. antibiotics use and hospitalisation) were more 
indicative of disease severity but may be subject to clinical judgement and therefore, 
be less sensitive measures of disease severity. Accordingly, we observed no 
significant differences in the outcomes for children with single infection and those 
with co-detection.  
 
This is consistent with data from previous systematic reviews, which found negligible 
differences between outcomes in children and adults with co-detection compared to 
peers with single infection [18,19]. However, further analyses by pathogen pairs 
suggest that some combinations of specific viral pathogens, such as influenza and 
RSV, are potentially more significant than others. This corroborates data from our 
recently completed systematic review that specifically investigated clinical outcomes 
in children with co-detection and found no differences overall but suggest that some 
pathogen specific effects may be present [20]. Our data suggest that future research 
in this area should segregate analysis by specific pathogen pairs where numbers 
allow.  
 
We chose to exclude bocavirus and enterovirus detections from the analyses as their 
pathogenicity in ARTI is still not well-established. Bocavirus is often implicated in 
both symptomatic and asymptomatic co-detection and is thought to have a 
prolonged period of shedding [6]; both features which may confound any 
associations between co-detection and clinical severity. On the other hand, studies 
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on the role of enteroviruses in ARTI are suggestive of pathogenicity [21], however 
the numbers are small. For these reasons, detections of both viruses were excluded 
from the analyses presented here. Repeat analyses including these viruses did not 
change the overall findings (see Supplementary Tables 1 and 2).  
 
An important consideration when interpreting these findings is the inability to 
distinguish between active (and pathogenic) infection and viral shedding. Prolonged 
viral shedding for some respiratory viruses, particularly rhinovirus, have been well-
documented [22,23]. Quantitative analyses may be of assistance in distinguishing 
these clinical states yet has not become commonplace in the diagnostic laboratory 
for respiratory viruses.  
 
One limitation of our study is that only children presenting to one hospital with 
influenza-like illness and fever were eligible for enrolment in this study. 
Consequently, it is possible that these children were at the more severe end of the 
disease spectrum which may bias our results. During the course of this study, there 
was a shift from using an antigen-based assay to using PCR when detecting hMPV, 
although both methods were used throughout the study period. We have elected to 
include detections from both methods but acknowledge that differences in the 
performance of these methods would mean that potential cases of hMPV may have 
been missed in earlier samples. These changes, as well as clinical discretion in 
testing for hMPV, may explain the lower proportions of hMPV detections in this 
cohort compared to other studies [24,25]. 
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Further limitations of this study include missing outcomes data, particularly for 
antibiotic prescription. In addition, data on diagnosis at discharge were not collected, 
which may have helped to indicate the severity of symptoms. Moreover, despite 
enrolling nearly 2500 children, the number of patients with infections with specific 
pathogens and pathogen-pairs were relatively small.  
 
Future studies using routinely collected, linked administrative data may assist in 
addressing both issues. Nonetheless, this is one of the largest single-site studies 
specifically investigating the effects of co-detection in young children using a wide 
panel of respiratory pathogens. Our results are similar to those reported elsewhere, 
adding to the validity of the findings [26]. 
 
We conclude that the impact of co-detection on disease severity in children 
presenting with influenza-like illness is likely to be limited to specific pathogen pairs. 
Therefore, routine screening for co-detection in this population should be restricted 
to common respiratory pathogens and efforts to reduce cross infection should focus 
on these specific pathogens. 
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9 Tables  1 
9.1 Table 1 – Cohort characteristics by infection status 2 
 3 
Description Frequency (n=2356) 
 No pathogen (n=726) Single infection (n=1226) Co-detection (n=404) 
 n % (95% CI) n % (95% CI) n % (95% CI) 
Aged less than 2 years 382 52.62 (48.91-56.30) 628 51.22 (48.38-54.06) 264 65.35 (60.48-69.98) 
Male 397 54.68 (50.98-58.35) 668 54.49 (51.65-57.30) 228 56.44 (51.44-61.33) 
Aboriginal or Torres Strait Islander 
descent 
33 4.55 (3.15-6.32) 71 5.79 (4.55-7.25) 31 7.67 (5.27-10.71) 
Born preterm 102 14.05 (11.60-16.79) 158 12.89 (11.06-14.89) 59 14.60 (11.31-18.43) 
One or more comorbidities 117 16.12 (13.51-19.00) 183 14.93 (12.98-17.05) 55 13.61 (10.42-17.35) 
More than 4 hours in out-of-home care 442 60.88 (57.22-64.45) 825 67.29 (64.59-69.91) 299 74.01 (69.44-78.22) 
Smoking in household 154 21.21 (18.29-24.37) 283 23.08 (20.75-25.55) 107 26.49 (22.24-31.07) 
Influenza vaccine on year of admission 188 25.90 (22.74-29.24) 303 24.71 (22.32-27.23) 100 24.75 (20.62-29.26) 
 4 
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24 
Note: CI=Confidence Intervals. Exact 95% CI presented. Denominators include cases with missing data. Detections of enterovirus 5 
or bocavirus were ignored in counts of single and co-detection.   6 
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25 
9.2 Table 2 – Frequency and logistic regression models of symptoms and outcomes by infection type 7 
 8 
Description Frequency Logistic regression models 
  Single infection (n=1226) Co-detection (n=404) Co-detection Co-detection  
  % (95% CI) % (95% CI) OR a (95% CI) aOR a,b (95% CI) 
Symptoms         
 Cough 88.66 (86.75-90.38) 93.32 (90.43-95.55) 1.95 (1.24-3.06) 1.94 (1.21-3.13) 
 Rhinorrhoea 88.09 (86.15-89.85) 93.32 (90.43-95.55) 2.07 (1.32-3.23) 1.79 (1.12-2.85) 
 Wheezing 43.56 (40.76-46.39) 49.01 (44.03-54.00) 1.26 (1.01-1.58) 1.20 (0.94-1.52) 
 Dyspnoea 45.84 (43.02-48.68) 50.74 (45.75-55.72) 1.23 (0.98-1.55) 1.15 (0.91-1.47) 
 Rash 17.86 (15.76-20.12) 14.11 (10.86-17.89) 0.75 (0.55-1.03) 0.69 (0.49-0.95) 
 Diarrhoea 20.39 (18.17-22.76) 27.23 (22.94-31.85) 1.47 (1.13-1.90) 1.33 (1.01-1.74) 
 Vomiting 38.58 (35.85-41.37) 42.82 (37.94-47.81) 1.19 (0.94-1.50) 1.16 (0.91-1.48) 
Outcomes         
 Antibiotics given c 19.98 (17.78-22.33) 21.53 (17.62-25.87) 1.19 (0.86-1.63) 1.11 (0.79-1.54) 
 Admitted to hospital 24.55 (22.16-27.06) 26.24 (22.01-30.82) 1.13 (0.87-1.46) 1.09 (0.83-1.44) 
 9 
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26 
Note: CI=confidence intervals. Denominators include those with missing data. The number of children with missing data are as 10 
follows: cough (n=4 for single infection; n=3 for co-detection), rhinorrhoea (n=4; n=3), wheezing (n=4; n=4), dyspnoea (n=5; n=4), 11 
rash (n=30; n=9), diarrhoea (n=30; n=10), vomiting (n=32; n=9), antibiotics given (n=587; n=199), admitted to hospital (n=6; n=2). 12 
Infections with either enterovirus or bocavirus were ignored in counts of single infection and co-detection.  13 
 14 
a Models presented are the odds of having a symptom/outcome in children with co-detection compared with children with single 15 
infection. 16 
b Models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and 17 
household smoking. All covariates listed were inputted as categorical variables. 18 
c Data were only available for 639 children with single infection and 205 children with co-detection.  19 
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10 Figure legends 20 
Figure 1 – Frequency of pathogen detection and co-detection 21 
Figure 2 – Probability of post-enrolment antibiotics use by pathogen pairs with 95% 22 
confidence intervals 23 
Figure 3 - Probability of hospitalisation by pathogen pairs with 95% confidence intervals24 
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11 Figures 25 
11.1 Figure 1 – Frequency of pathogen detection and co-detection 26 
 27 
Note: RSV=respiratory syncytial virus, hMPV = human metapneumovirus. Detections of enterovirus and bocavirus were excluded 28 
from subsequent analyses.   29 
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29 
11.2 Figure 2 – Probability of post-enrolment antibiotics use by pathogen pairs with 95% confidence intervals 30 
 31 
Note: RSV=respiratory syncytial virus.  32 
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30 
11.3 Figure 3 – Probability of hospitalisation by pathogen pairs with 95% confidence intervals 33 
 34 
Note: RSV=respiratory syncytial virus. 35 
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Supplementary Table 1 – Cohort characteristics by infection status (all viruses included) 
Description Frequency (n=2356) 
 No pathogen (n=542) Single infection (n=1228) Co-detection (n=586) 
 n % (95% CI) n % (95% CI) n % (95% CI) 
Aged less than 2 years 279 51.48 (47.18-55.76) 611 49.76 (46.91-52.59) 384 65.53 (61.52-69.38) 
Male 293 54.06 (49.76-58.31) 664 54.07 (51.24-56.89) 336 57.34 (53.22-61.38) 
Aboriginal or Torres Strait 
Islander descent 
26 4.80 (3.16-6.95) 72 5.86 (4.62-7.33) 37 6.31 (4.48-8.60) 
Born preterm 70 12.92 (10.21-16.03) 163 13.27 (11.42-15.30) 86 14.68 (11.91-17.80) 
Has 1 or more comorbidities 92 16.97 (13.91-20.40) 186 15.15 (13.19-17.28) 77 13.14 (10.51-16.15) 
More than 4 hours in out-of-
home care 
346 63.84 (59.63-67.89) 812 66.12 (63.40-68.77) 408 69.62 (65.72-73.33) 
Has smoking in household 119 21.96 (18.54-25.68) 282 22.96 (20.64-25.42) 143 24.40 (20.98-28.09) 
Had influenza vaccine on 
year of admission 
150 27.68 (23.95-31.65) 306 24.92 (22.52-27.44) 135 23.04 (19.69-26.66) 
 
Note: CI=Confidence Intervals. Exact 95% CI presented. Denominators include cases with missing data.  
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Supplementary Table 2 – Frequency and logistic regression models of symptoms and outcomes by infection type (all viruses) 
 
Description Frequency Logistic regression models 
  Single infection (n=1228) Co-detection (n=586) Co-detection Co-detection 
  % (95% CI) % (95% CI) OR a (95% CI) aOR a,b (95% CI) 
Symptoms         
 Cough 87.87 (85.91-89.64) 91.47 (88.91-93.60) 1.53 (1.09-2.16) 1.63 (1.12-2.36) 
 Rhinorrhoea 86.64 (84.61-88.50) 92.32 (89.86-94.34) 1.94 (1.36-2.76) 1.72 (1.18-2.51) 
 Wheezing 43.08 (40.29-45.90) 48.63 (44.52-52.77) 1.26 (1.03-1.54) 1.23 (0.99-1.53) 
 Dyspnoea 44.87 (42.06-47.70) 51.19 (47.06-55.31) 1.30 (1.07-1.58) 1.27 (1.03-1.57) 
 Rash 17.59 (15.50-19.84) 15.70 (12.85-18.90) 0.87 (0.66-1.13) 0.82 (0.62-1.08) 
 Diarrhoea 19.95 (17.75-22.30) 24.57 (21.14-28.27) 1.31 (1.03-1.65) 1.17 (0.91-1.50) 
 Vomiting 38.93 (36.19-41.72) 40.44 (36.44-44.54) 1.06 (0.86-1.29) 1.03 (0.84-1.28) 
Outcomes         
 Antibiotics given c 19.71 (17.52-22.04) 20.99 (17.76-24.51) 1.09 (0.82-1.44) 0.98 (0.73-1.31) 
 Admitted to hospital 24.35 (21.97-26.85) 28.16 (24.55-31.99) 1.22 (0.97-1.52) 1.18 (0.92-1.49) 
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Note: CI=confidence intervals. Denominators include those with missing data. The number of children with missing data are as follows: cough 
(n=4 for single infection; n=3 for co-detection), rhinorrhoea (n=4; n=3), wheezing (n=4; n=4), dyspnoea (n=5; n=4), rash (n=32; n=13), diarrhoea 
(n=33; n=14), vomiting (n=34; n=13), antibiotics given (n=601; n=283), admitted to hospital (n=6; n=2).  
 
a Models presented are the odds of having a symptom/outcome in children with co-detection compared with children with single infection. 
b Models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and household smoking. 
All covariates listed were inputted as categorical variables. 
c Data were only available for 627 children with single infection and 283 children with co-detection.  
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Abstract 
Background 
Viral coinfection in cChildren with acute respiratory tract infection (ARTI) is frequently 
reportexhibit viral-viral co-detectioned, yet its clinical significance remains 
contentious. Using data from a prospective cohort of children with influenza-like 
illness, we described the virology of ARTI and determined the clinical impact of viral-
viral coinfectionco-detection. 
 
Methods 
Children aged 6-59 months presenting to a tertiary paediatric hospital with fever and 
acute respiratory symptoms were enrolled and nasal samples collected in an 
influenza vaccine effectiveness study during influenza seasons in from 2008- to 
2012. Respiratory vViruses were identified by culture and PCR from nasal swabs. 
We compared the demographics, presenting symptoms and clinical outcomes of 
children with single viral infection and viral-viral coinfectionco-detection. We then 
used logistic regression models and estimated marginal means to calculate the 
adjusted odds ratio and probabilities of symptom presentation, antibiotic prescription 
or hospitalisation, adjusted for demographic factors.  
 
Results 
Of 2487 eligible patients, 1728 1630 of 2356 children (69.2%) had a virus detected, 
among whom rhinovirus (40.8%), influenza (29.5%) and respiratory syncytial virus 
(RSV; 26.4%) were most commonly detected. 24% of these had of which 24% were 
coinfected with two or more viruses detected. After . Rhinovirus (40%), influenza 
(29%) and respiratory syncytial virus (RSV; 27%) were the most commonly detected 
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viruses. aAdjusting for other demographic factors, children with co-detection 
coinfection had greater odds of presenting with cough (aOR=2.01.9, 95% CI:=1.32-
3.1.2),  and rhinorrhoea (aOR=1.98, 95% CI:=1.21-2.9) than those with single 
infection, although both symptoms were common. Children with Comparing virus-
virus combinations, influenza and RSV combined was associated withhad the the 
highest st probability of antibiotics prescription (probability=58%, 95%CI=33-79%) 
and hospitalisation (probability=554%, 95%CI:=354-73%), significantly greater than 
those with influenza infection alone (probability=22%, 95%CI:16-29%).  
. 
 
Conclusions 
Overall, coinfectionco-detection has limited impact on clinical severity among 
children with influenza-like illness. However, specific pathogen pairs may be 
associated with more severe outcomes. Routine diagnostics to identify viral Future 
research should segregate by pathogen where feasible. Routine screening for 
coinfectionco-detection should be restricted to common pathogens. 
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1 Introduction 
Acute respiratory tract infections (ARTI) in children place a significant burden on 
families and the community. Commonly recognized respiratory viral pathogens 
include influenza viruses, respiratory syncytial viruses (RSV), parainfluenza viruses, 
human rhinoviruses, adenoviruses and coronaviruses [1,2]. Advances in laboratory 
diagnostic techniques have resulted in the discovery of new viruses, including 
human metapneumovirus (hMPV) and polyomaviruses [3,4], yet a number of these 
pathogens have . These advances have also enabled greater delineation between 
pathogenic viruses and viruses of uncertain pathogenicity [5,6].  
 
CoinfectionCo-detection can be defined as detection of two or more pathogens in a 
single sample. With the improved sensitivity, availability and affordability of modern 
diagnostics, viral-viral coinfectionco-detections are being increasingly identified. The 
incidence of viral-viral coinfectionco-detection has been reported between 15-45%, 
depending on age, location and testing methods [7–9]. The clinical significance of 
coinfectionco-detection in ARTI remains contentious with the literature ranging  as 
current evidence ranges from negligible to deleterious effects [9,10]. 
 
This study describes the virology of ARTI in children aged six months to four years 
who, presenteding to a paediatric emergency department with influenza-like illness 
during influenza season to a tertiary paediatric hospital in Australia. This study also 
enabled us to specifically examine, and determines the impact of viral-viral 
coinfectionco-detection on clinical symptoms and outcomes. 
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2 Materials and Methods 
2.1 Study setting and patients 
Western Australia (WA) spans 2.5 million square kilometres with a population of 
approximately 2.5 million people, 7% of whom are under 5 years of age [11]. 
Princess Margaret Hospital for Children (PMH) is the only tertiary paediatric hospital 
in the state and is located in metropolitan Perth where approximately 80% of the 
population resides [12]. 
 
Commencing in 2008, tThe Western Australia Influenza Vaccine Effectiveness 
(WAIVE) Study was an observational cohort study established to determine the 
effectiveness of inactivated influenza vaccinecommenced in 2008. Patient 
recruitment was conducted at PMH (and at selected general practises in 
metropolitan WA in 2008-2009). Due to small numbers recruited and differences in 
presentation, data from children presenting to general practises were removed from 
these analyses.  
 
Patient recruitment coincided with the annual influenza seasons. and is an 
observational study conducted during the annual influenza season. The start and 
end of influenza seasons were defined by the Infectious Diseases Surveillance Unit 
at PathWest Laboratory Medicine WA using a combination of indicators, including 
weekly proportion of laboratory influenza tests positive. As a guide, two consecutive 
weeks with over 10% influenza test positive often coincides with the beginning of 
influenza season in WA. Further details on The study design are is described 
elsewhere [13].  
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In summary, Aall children 6-59 months of age presenting to PMH with a history of 
fever (by parental report) or with a measured temperature of greater than 37.5°C at 
presentation, accompanied by at least one acute respiratory symptoms within the 
previous 96 hours, were eligible for enrolment. All children transited through PMH 
emergency department. A portion of these children were subsequently admitted to 
hospital with the remainder discharged home from the emergency department. While 
the bulk of recruitment occurred at PMH emergency department, children may also 
be recruited from PMH inpatient facilities or from general practices (2008 only). 
Influenza seasons each year were determined by influenza surveillance data in the 
state [13]. Children with a known immunodeficiency disorder, current or recent 
immunosuppressive treatment, or who received immunoglobulin in the previous 
three months were excluded from the study.  
 
Patient demographics, medical history and presenting symptoms were collected by 
parental questionnaire. Comorbidities recorded included prematurity, asthma, 
chronic cardiac, neurological or respiratory conditions. Influenza vaccination status 
was obtained by parental report and confirmed through the Australian Childhood 
Immunisation Register or by contacting immunisation providers. Vaccination status 
for other vaccines were not collected. A follow-up questionnaire of illness outcomes, 
including details of hospital admission(s), use of antibiotics and time to recovery, was 
provided to families to complete within 7-10 days after enrolment. A retrospective 
review of medical records was undertaken when hospitalisation data were incorrectly 
recorded or missing. No follow-up was conducted for antibiotics use if data were 
missing.  
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2.2 Respiratory virus detection 
Children had a bilateral mid-turbinate nasopharyngeal nasal swabs or aspirate 
collected at enrolment (Copan Diagnostics Inc., Murrieta, CA). If a nasopharyngeal 
aspirate had already been collected by hospital staff as part of clinical care, this 
sample was used in lieu of a nasal swab. Viral culture (Madin-Darby Canine Kidney 
cells, Diploid lung fibroblasts) and multiplex tandem PCR was used to detect all 
viruses except enterovirus, rhinoviruspicornaviruses and hMPV [14,15]. 
Enteroviruses and rhinovirusesPicornaviruses were detected using nested PCR [16] 
targeting the 5’UTR of the picornavirus genome with sequencing used to assist with 
identification of rhinoviruses and enterovirusesspeciation. hMPV was tested using an 
immunofluorescent assay (Simulfluor hMPV Immunofluoresent Assay; Millipore, 
Temecula, CA) and PCR. All patients were subjected to the same panel of tests and 
testing methods were consistent throughout the study period with the exception of 
testing for hMPV; testing for hMPV was based on clinical need. While both 
immunofluorescence and PCR assays were used throughout the study period, PCR 
testing was more common in later years. 
 
For all viruses (except hMPV), positive viral detection was defined as detection by 
viral culture and/or PCR. Positive detection of hMPV was defined as detection by 
immunofluorescence and/or PCR. All influenza types/subtypes (i.e. influenza 
A/H1N1, A/H3N2 and B) were grouped for analysis. Similarly, sSubgroups of 
influenza viruses and parainfluenza viruses (i.e. parainfluenza types 1-4) were 
grouped together for analysis. Infection was defined as detection of one or more of 
rhinovirus, influenza, RSV, parainfluenza, adenovirus, coronavirus or hMPV. 
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CoinfectionCo-detection was defined as detection of two or more viruses in a single 
diagnostic sample.  
 
2.3 Definitions and statistical analysis 
Prematurity was defined as less than 37 weeks of gestation at birth. Out-of-home 
care was defined as attendance at playgroup, mothers’ group, day-care centre, 
kindergarten or preschool for four or more hours per week. Length of stay in hospital 
refers to the duration from admission to discharge date. Symptoms investigated 
included cough, rhinorrhoea, wheeze, dyspnoea, rash, diarrhoea and vomiting while 
outcomes investigated were antibiotic prescription and hospital admission. 
 
Data cleaning and analyses were performed in Microsoft Excel, EpiBasic [17] and 
SPSS version 232 (SPSS Inc., Chicago, IL). Categorical variables were compared 
using Pearson’s chi-squared tests. Logistic regression models were used to 
calculate odds ratios (OR) with 95% confidence intervals (CI) to compare those with 
single infection to those with coinfectionco-detection. Dependent variables were 
symptom (e.g. presence of cough or rhinorrhoea) and outcome variables (e.g. 
hospitalisation or use of antibiotics). 
 
We calculated adjusted ORs (aORs) by including the following covariates in the 
logistic regression models: age, gender, Aboriginal status, prematurity, presence of 
comorbidities, out-of-home care and household smoking. Age was included as a 
categorical variable in the models and were divided into 6-11 months, 12-23 months, 
2 years, 3 years and 4 years (reference group). Covariates were selected based on 
known epidemiological or clinical risk factors for co-detection. Records with missing 
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data for any of the covariates were excluded from the fully adjusted models. Data 
from all patients were included in the adjusted models unless they had missing data 
on one or more covariates. To investigate the impact of specific pathogen pairs, 
analyses were repeated for the most common pathogen pairs. Estimated marginal 
means Post-hoc analysis of selected logistic regression models wereas used to 
calculate probabilities with 95% CIs for antibiotic prescribing and hospitalisation for 
common pathogen pairs.  
 
2.4 Ethical approvals 
This study was approved by the PMH Human Research Ethics Committee 
(1673/EP), the Western Australian Aboriginal Health Ethics Committee (212 06/08) 
and the University of Western Australia Research Ethics Committee (RA/4/1/6456).  
 
3 Results 
Of 2715 patients recruited from 2008 to 2012, data for 2487 2356 patients were 
available for analysis. Reasons for exclusion included incorrect or unknown age 
(n=154, 67.542.9% of all excluded patients), recruitment from general practice in 
2008-2009 (n=131, 36.5%) , incomplete pathogen testing not completed (n=29, 
12.78.1%), unknown vaccination history (n=7, 3.11.9%), incomplete data (n=12, 
5.33.3%), multiple enrolments for the same episode of illness (n=3, 1.30.8%),  or 
withdrawal from the study (n=23, 10.16.4%).  
 
Of the 2356 patients enrolled, the majority (n=1848, 78.4%) were enrolled while 
presenting to PMH emergency department. Of these 6.3% (n=117) were 
subsequently admitted to hospital. Of those included in analyses, Tthe median age 
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was 22.0 months (interquartile range=14.0-356.0), 554.9.2% were male and 5.67% 
were of Aboriginal or Torres Strait Islander decent. Children born preterm accounted 
for 13.35% (n=319) of patients. Children with comorbidities accounted for 15.1% 
(n=355) of this cohort. Of those that had one or more comorbidity, asthma (n=21825, 
62.061.4%) and other chronic respiratory conditions (n=54, 15.2%, 14.9%) were 
most common. 
 
 
Of 2356 patients, 52.8% (n=1244) completed questions relating to outcomes (e.g. 
antibiotics use). Although parents were requested to complete these questions 7-10 
days post-enrolment, yet the mean time to completion was 19.3 days and ranged 
from 0 to 149 days (median=10 days). Data on antibiotic prescription post-enrolment 
were available for 51.052.6% (n=13081201) of patients, of whom 542483 
(41.440.2%) were prescribed antibiotics. Combining data from questionnaires and 
review of hospital records resulted in near-complete data on hospitalisation (99.4%, 
n=2341), Hospitalisation data were available for 99.0% (n=2462) of patients, of 
whom 596 610 (26.14.2%) were hospitalized. Of those who were admitted to 
hospital, the median length of stay was 2 days (interquartile range=1-3).  
 
Overall, 1630728 patients (69.569.2%) tested positive for a virus. Of those with at 
least one virus detected, the most , most common werely rhinovirus (n=665, 40.8%), 
influenza (n=481, 29.5%) and RSV (n=431, 26.4%; Figure 1). Of those with at least 
onea virus detected, 24.84% (n=404) had at least one other virus co-detectedwere 
coinfected. Of these, 36750 (86.687.1%) had were infected with 2 viruses detected, 
Formatted: Not Highlight
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52 (12.94%) had were infected with 3 viruses detected and the remainder with 4 or 
more viruses.  
 
A greater proportion of Cchildren with multiple viruses  coinfectiondetected were less 
than 2 years old (65.4%) younger (median age=18.0 months, interquartile 
range=12.0-29.0) and attended out-of-home-care more compared to those with a 
single virus infection (51.2%, p<0.001median age=23.0 months, interquartile 
range=14.0-37.5; Table 1). Those with coinfectionco-detection also had greater 
double the odds of presenting with cough and rhinorrhoea compared to those with 
single infection, although both symptoms were common in both groups (Table 2). 
This effect remained after adjusting for other covariates. Of note, although less 
common, diarrhoea was more frequently observed in children with viral co-detection. 
There were no significant differences in the odds of being prescribed antibiotics 
(aOR=1.1, 95%CI: 0.8,1.5) or hospitalised (aOR=1.1, 95%CI: 0.8,1.4) between 
patients with single infection and coinfectionco-detection (Table 2).  
 
We then selected the three most common pathogens (rhinovirus, influenza and RSV) 
and investigated associations of specific pathogen pairs with antibiotic prescription 
and hospitalisation. After adjusting for other covariates, patients coinfected with both 
an influenza and /RSV pair detected had a 528% probability (95% CI:=2833%-796%) 
of being prescribed antibiotics with a trend towards more frequent prescription when 
compared with those with influenza or RSV infection alone (Figure 2). Similarly, the 
probability of being hospitalised was highest in those coinfected with influenza and 
RSV detected (probability=554%, 95% CI:=345%-73%); significantly greater when 
compared with those with influenza infection alone (probability=272%, 
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95%CI:=156%-289%; ) with a non-significant trend observed when compared with 
those with RSV infection alone (probability=41%, 95%CI=34%-49%). No other 
differences were noted when comparing coinfection and single infection with other 
pathogen pairs (Figure 3) and with a trend observed compared with RSV infection 
alone (probability=43%, 95%CI:36-51%)..  
 
4 Discussion 
This is one of the largest, single-site prospective studies of children up to 4 years of 
age that specifically investigates the incidence of and clinical outcomes associated 
with viral-viral coinfectionco-detection. Our findings demonstrate that although 
significant differences in demographics, risk factors and symptoms are identifiable, in 
general, viral-viral coinfectionco-detection is unlikely to be associated with more 
severe clinical illness among young children with influenza-like illness. However S, 
specific pathogen pairs may be associated with an increased probability of 
hospitalisation as was observed with influenza and RSV. This finding has significant 
implications in paediatric healthcare facilities where isolation of all children with acute 
respiratory viral infection is difficult during periods of peak respiratory virus activity 
and cohorting of children is frequently required prior to the availability of diagnostic 
test results.  
 
We detected small differences in the symptoms presented by patients with single 
infection compared to those with coinfectionco-detection. However, these symptoms 
were common and therefore, likely to be of little clinical relevance. On the other 
hand, the clinical outcomes chosen (i.e. antibiotics use and hospitalisation) were 
more indicative of disease severity but may beare subject to clinical judgement and 
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therefore, may be less insensitive measures of disease severity. Accordingly, we 
observed no significant differences in the outcomes for children with single infection 
and those with coinfectionco-detection.  
 
This is consistent with data from previous systematic reviews, which found negligible 
differences between outcomes in children and adults with coinfectionco-detection 
compared to peers with single infection [18,19]. However, further analyses by 
pathogen pairs suggest that some virus combinations of specific viral pathogens, 
such as influenza and RSV, are potentially more pathogenic significant than others. 
This corroborates data from our recently completed systematic review that 
specifically investigated clinical outcomes in children with coinfectionco-detection 
and found no differences overall but suggest that some pathogen specific effects 
may be present  (PROSPERO registration: CRD#42014009133).[20]. Our data 
suggest that future research in this area should segregate analysis by specific 
pathogen pairs where numbers allow.  
 
We chose to exclude bocavirus and enterovirus detections from the analyses as their 
pathogenicity in ARTI is still not well-established. Bocavirus is often implicated in 
both symptomatic and asymptomatic coinfectionco-detection and is thought to have 
a prolonged period of shedding [6]; both features which may confound any 
associations between coinfectionco-detection and clinical severity. On the other 
hand, studies on the role of enteroviruses in ARTI are suggestive of pathogenicity 
[21], however the numbers are small. For these reasons, detections of both viruses 
were excluded from the analyses presented here. Repeat analyses including these 
viruses did not change the overall findings (see Supplementary Tables 1 and 2).  
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An important consideration when interpreting these findings is the inability to 
distinguish between active (and pathogenic) infection and viral shedding. Prolonged 
viral shedding for some respiratory viruses, particularly rhinovirus, have been well-
documented [22,23]. Quantitative analyses may be of assistance in distinguishing 
these clinical states yet has not become commonplace in the diagnostic laboratory 
for respiratory viruses.  
 
We attempted to investigate the relationship between rhinovirus infection and clinical 
severity [22–24]. However, we were limited as we were unable to subtype 
rhinoviruses; in particular, rhinovirus-C has been associated with greater respiratory 
illness than subtype A [5]. Based on the proportion of patients who were hospitalised 
with influenza and rhinovirus infections in this cohort, data from approximately 7700 
children would have been required to provide 80% power of detecting a difference, at 
the 0.05 level of significance, between those with a rhinovirus-C infection and those 
with an influenza virus infection.  
 
One limitation of our study is that only children presenting to one hospital with 
influenza-like illness and fever were eligible for enrolment in this study. 
Consequently, it is possible that these children were at the more severe end of the 
disease spectrum which may bias our results. During the course of this study, there 
was a shift from using an antigen-based assay to using PCR when detecting hMPV, 
although both methods were used throughout the study period. We have elected to 
include detections from both methods but acknowledge that differences in the 
performance of these methods would mean that potential cases of hMPV may have 
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been missed in earlier samples. These changes, as well as clinical discretion in 
testing for hMPV, may explain the lower proportions of hMPV detections in this 
cohort compared to other studies [24,25]. 
 
Further limitations of this study include missing outcomes data, particularly for 
antibiotic prescription. . In addition, data on diagnosis at discharge were not 
collected, which may have helped to indicate the severity of symptoms. Moreover, 
despite enrolling nearly 2500 children, the number of patients with infections with 
specific pathogens and pathogen-pairs were relatively small.  
 
Future studies using routinely collected, linked administrative data may assist in 
addressing both issues. Nonetheless, this is one of the largest single-site studies 
specifically investigating the effects of coinfectionco-detection in young children 
using a wide panel of respiratory pathogens. Our results are similar to those reported 
elsewhere, adding to the validity of the findings [26]. 
 
We conclude that the impact of coinfectionco-detection on disease severity in 
children presenting with influenza-like illness is likely to be limited to specific 
pathogen pairs. Therefore, routine screening for coinfectionco-detection in this 
population should be restricted to common respiratory pathogens and efforts to 
reduce cross infection should focus on these specific pathogens. 
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9 Tables  1 
9.1 Table 1 – Cohort characteristics by infection status 2 
 3 
Description Frequency (n=24872356) 
 No pathogen (n=726759) Single infection (n=12261307) CoinfectionCo-detection 
(n=404421) 
 n % (95% CI) n % (95% CI) n % (95% CI) 
Aged less than 2 years 382392 52.62
51.65 
(48.91-(48.03-
55.26)56.30) 
6286
72 
51.225
1.42 
(48.38-
54.06)(48.67-
54.16) 
264
271 
65.356
4.37 
(60.48-
69.98)(59.59-
68.95) 
Male 397414 54.68
54.55 
(50.98-
58.35(50.93-
58.13)) 
6687
17 
54.495
4.86 
(51.65-
57.30)(52.11-
57.58) 
228
241 
56.445
7.24 
(51.44-
61.33)(52.36-
62.02) 
Aboriginal or Torres Strait Islander 
descent descent 
3334 4.554.
48 
(3.12-
6.20)(3.15-
6.32) 
7174 5.795.
66 
(4.55-
7.25)(4.47-
7.06) 
313
1 
7.677.
36 
(5.27-
10.71)(5.06-
10.29) 
Born preterm 102106 14.05 (11.60- 1581 12.891 (11.06- 596 14.601 (11.31-
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25 
13.97 16.79(11.58-
16.64)) 
65 2.62 14.89)(10.87-
14.55) 
0 4.25 18.43)(11.06-
17.96) 
One or more comorbidities 117118 16.12
15.55 
(13.51-
19.00(13.04-
18.32)) 
1831
89 
14.931
4.46 
(12.98-
17.05)(12.60-
16.49) 
555
6 
13.611
3.30 
(10.42-
17.35)(10.21-
16.92) 
More than 4 hours in out-of-home care 442459 60.88
60.47 
(57.22-
64.45(56.90-
63.97)) 
8258
72 
67.296
6.72 
(64.59-
69.91)(64.09-
69.27) 
299
307 
74.017
2.92 
(69.44-
78.22)(68.41-
77.11) 
Smoking in household 154165 21.21
21.74 
(18.29-
24.37(18.85-
24.85)) 
2833
05 
23.082
3.34 
(20.75-
25.55)(21.07-
25.73) 
107
110 
26.492
6.13 
(22.24-
31.07)(21.99-
30.60) 
Influenza vaccine on year of admission 188213 25.90
28.06 
(22.74-
29.24(24.89-
31.41)) 
3033
64 
24.712
7.85 
(22.32-
27.23)(25.43-
30.37) 
100
111 
24.752
6.37 
(20.62-
29.26)(22.22-
30.85) 
 4 
Note: CI=Confidence Intervals. Exact 95% CI presented. Denominators include cases with missing data. Detections of enterovirus 5 
or bocavirus were ignored in counts of single and coinfectionco-detection.   6 
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26 
9.2 Table 2 – Frequency and logistic regression models of symptoms and outcomes by infection type 7 
 8 
Description Frequency Logistic regression models 
  Single infection (n=1226) Co-detection (n=404) Co-detection Co-detection  
  % (95% CI) % (95% CI) OR a (95% CI) aOR  
a,ba 
(95% CI) 
Symptoms         
 Cough 88.66 (86.75-90.38) 93.32 (90.43-95.55) 1.95 (1.24-3.06) 1.94 (1.21-3.13) 
 Rhinorrhoea 88.09 (86.15-89.85) 93.32 (90.43-95.55) 2.07 (1.32-3.23) 1.79 (1.12-2.85) 
 Wheezing 43.56 (40.76-46.39) 49.01 (44.03-54.00) 1.26 (1.01-1.58) 1.20 (0.94-1.52) 
 Dyspnoea 45.84 (43.02-48.68) 50.74 (45.75-55.72) 1.23 (0.98-1.55) 1.15 (0.91-1.47) 
 Rash 17.86 (15.76-20.12) 14.11 (10.86-17.89) 0.75 (0.55-1.03) 0.69 (0.49-0.95) 
 Diarrhoea 20.39 (18.17-22.76) 27.23 (22.94-31.85) 1.47 (1.13-1.90) 1.33 (1.01-1.74) 
 Vomiting 38.58 (35.85-41.37) 42.82 (37.94-47.81) 1.19 (0.94-1.50) 1.16 (0.91-1.48) 
 At least 1 symptom 97.55 (96.53-98.34) 99.26 (97.85-99.85)     
Outcomes         
 Antibiotics given cb 19.98 (17.78-22.33) 21.53 (17.62-25.87) 1.19 (0.86-1.63) 1.11 (0.79-1.54) 
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27 
 Admitted to hospital 23.9824.55 (21.61-26.4722.16-
27.06) 
26.24 (22.01-30.82) 1.13 (0.87-1.46) 1.09 (0.83-1.44) 
 9 
Note: CI=confidence intervals. Denominators include those with missing data. The number of children with missing data are as 10 
follows: cough (n=4 for single infection; n=3 for co-detection), rhinorrhoea (n=4; n=3), wheezing (n=4; n=4), dyspnoea (n=5; n=4), 11 
rash (n=30; n=9), diarrhoea (n=30; n=10), vomiting (n=32; n=9), antibiotics given (n=587; n=199), admitted to hospital (n=6; n=2).  12 
Infections with either enterovirus or bocavirus were ignored in counts of single infection and coinfectionco-detection.  13 
Adjusted models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and 14 
household smoking. Models presented are the odds of having a symptom/outcome in children with coinfection compared with 15 
children with single infection.  16 
a Models presented are the odds of having a symptom/outcome in children with co-detection compared with children with single 17 
infection. 18 
b Models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and 19 
household smoking. All covariates listed were inputted as categorical variables. 20 
ac Data were only available for 706 639 children with single infection and 219 205 children with coinfectionco-detection.  21 Formatted: Highlight
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28 
10 Figure legends 22 
Figure 1 – Frequency of pathogen detection and coinfectionco-detection 23 
Figure 2 – Probability of post-enrolment use of antibiotics use by pathogen pairs with 95% 24 
confidence intervals 25 
Figure 3 - Probability of hospitalisation by pathogen pairs with 95% confidence intervals26 
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29 
11 Figures 27 
11.1 Figure 1 – Frequency of pathogen detection and coinfectionco-detection 28 
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31 
 30 
Note: RSV=respiratory syncytial virus, hMPV = human metapneumovirus. Detections of enterovirus and bocavirus were excluded 31 
from subsequent analyses.   32 
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32 
11.2 Figure 2 – Probability of use of post-enrolment antibiotics use  by pathogen pairs with 95% confidence intervals 33 
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 35 
Note: RSV=respiratory syncytial virus.  36 
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34 
11.3 Figure 3 – Probability of hospitalisation by pathogen pairs with 95% confidence intervals 37 
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Note: RSV=respiratory syncytial virus. 40 
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Supplementary Table 1 – Cohort characteristics by infection status (all viruses included) 
 
Description Frequency (n=23562487) 
 No pathogen (n=542573) Single infection (n=12281309) Co-detectioninfection 
(n=586605) 
 n % (95% CI) n % (95% CI) n % (95% CI) 
Aged less than 2 years 279288 51.485
0.26 
(47.18-
55.76)(46.09-
54.43) 
6116
54 
49.764
9.96 
(46.91-
52.59)(47.22-
52.71) 
384
393 
65.53
64.96 
(61.52-
69.38)(61.01-
68.76) 
Male 293310 54.065
4.10 
(49.76-
58.31)(49.92-
58.24) 
6647
12 
54.075
4.39 
(51.24-
56.89)(51.65-
57.12) 
336
350 
57.34
57.85 
(53.22-
61.38)(53.80-
61.82) 
Aboriginal or Torres Strait 
Islander descent 
2627 4.804.
71 
(3.16-
6.95)(3.13-
6.78) 
7275 5.865.
73 
(4.62-
7.33)(4.53-
7.13) 
373
7 
6.316
.12 
(4.48-
8.60)(4.34-
8.33) 
Born preterm 7074 12.921
2.91 
(10.21-
16.03)(10.28-
1631
69 
13.271
2.91 
(11.42-
15.30)(11.14-
868
8 
14.68
14.55 
(11.91-
17.80)(11.88-
Formatted Table
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15.94) 14.85) 17.61) 
Has 1 or more comorbidities 9293 16.971
6.23 
(13.91-
20.40)(13.30-
19.51) 
1861
92 
15.151
4.67 
(13.19-
17.28)(12.79-
16.70) 
777
8 
13.14
12.89 
(10.51-
16.15)(10.33-
15.83) 
More than 4 hours in out-of-
home care 
346361 63.846
3.00 
(59.63-
67.89)(58.90-
66.97) 
8128
61 
66.126
5.78 
(63.40-
68.77)(63.13-
68.35) 
408
416 
69.62
68.76 
(65.72-
73.33)(64.90-
72.43) 
Has smoking in household 119130 21.962
2.69 
(18.54-
25.68)(19.32-
26.34) 
2823
04 
22.962
3.22 
(20.64-
25.42(20.96-
25.61)) 
143
146 
24.40
24.13 
(20.98-
28.09)(20.77-
27.75) 
Had influenza vaccine on 
year of admission 
150174 27.683
0.37 
(23.95-
31.65)(26.62-
34.31) 
3063
66 
24.922
7.96 
(22.52-
27.44(25.54-
30.48)) 
135
148 
23.04
24.46 
(19.69-
26.66(21.09-
28.09)) 
 
Note: CI=Confidence Intervals. Exact 95% CI presented. Denominators include cases with missing data.  
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Supplementary Table 2 – Frequency and logistic regression models of symptoms and outcomes by infection type (all viruses) 
 
Description Frequency Logistic regression models 
  Single infection (n=13091228) Co-detectioninfection 
(n=605586) 
Co-
detectionCoinfection 
Co-
detectionCoinfection  
  % (95% CI) % (95% CI) OR a (95% CI) aOR a,b (95% CI) 
Symptoms         
 Cough 87.8787.55 (85.91-89.64)(85.64-
89.29) 
91.4791.24 (88.91-
93.60)(88.70-
93.37) 
1.531.54 (1.09-
2.16)(1.10-
2.16) 
1.631.65 (1.12-
2.36)(1.15-
2.37) 
 Rhinorrhoea 86.6486.78 (84.61-88.50)(84.83-
88.57) 
92.3292.40 (89.86-
94.34)(89.99-
94.38) 
1.941.96 (1.36-
2.76)(1.37-
2.79) 
1.721.75 (1.18-
2.51)(1.21-
2.54) 
 Wheezing 43.0842.63 (40.29-45.90)(39.93-
45.36) 
48.6347.93 (44.52-
52.77)(43.89-
52.00) 
1.261.25 (1.03-
1.54)(1.03-
1.52) 
1.231.22 (0.99-
1.53)(0.99-
1.50) 
 Dyspnoea 44.8744.23 (42.06-47.70)(41.52- 51.1950.25 (47.06- 1.301.28 (1.07- 1.271.24 (1.03-
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46.97) 55.31)(46.19-
54.31) 
1.58)(1.05-
1.55) 
1.57)(1.01-
1.53) 
 Rash 17.5917.34 (15.50-19.84)(15.33-
19.50) 
15.7015.37 (12.85-
18.90)(12.59-
18.50) 
0.870.86 (0.66-
1.13)(0.66-
1.12) 
0.820.81 (0.62-
1.08)(0.62-
1.07) 
 Diarrhoea 19.9520.63 (17.75-22.30)(18.46-
22.96) 
24.5724.46 (21.14-
28.27)(21.07-
28.09) 
1.311.24 (1.03-
1.65)(0.99-
1.56) 
1.171.11 (0.91-
1.50)(0.87-
1.41) 
 Vomiting 38.9338.35 (36.19-41.72)(35.71-
41.05) 
40.4440.66 (36.44-
44.54)(36.72-
44.70) 
1.061.10 (0.86-
1.29)(0.90-
1.34) 
1.031.07 (0.84-
1.28)(0.87-
1.32) 
Outcomes         
 Antibiotics given c 19.7121.62 (17.52-22.04)(19.42-
23.95) 
20.9921.65 (17.76-
24.51)(18.43-
25.15) 
1.091.01 (0.82-
1.44)(0.77-
1.33) 
0.980.92 (0.73-
1.31)(0.70-
1.22) 
 Admitted to hospital 24.3522.31 (21.97-26.85)(20.08-
24.66) 
28.1627.11 (24.55-
31.99)(23.60-
1.221.29 (0.97-
1.52)(1.03-
1.181.25 (0.92-
1.49)(0.98-
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30.84) 1.61) 1.58) 
 
Note: CI=confidence intervals. Denominators include those with missing data. The number of children with missing data are as follows: cough 
(n=4 for single infection; n=3 for co-detection), rhinorrhoea (n=4; n=3), wheezing (n=4; n=4), dyspnoea (n=5; n=4), rash (n=32; n=13), diarrhoea 
(n=33; n=14), vomiting (n=34; n=13), antibiotics given (n=601; n=283), admitted to hospital (n=6; n=2).  
 
a Models presented are the odds of having a symptom/outcome in children with co-detection compared with children with single infection. 
b Models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and household smoking. 
All covariates listed were inputted as categorical variables. 
c Data were only available for 627 children with single infection and 283 children with co-detection.  
Adjusted models were adjusted for age, gender, Aboriginal status, preterm birth, presence of comorbidities, out-of-home care and household 
smoking. Models presented are the odds of having a symptom/outcome in children with coinfection compared with children with single infection.  
 
a Data were only available for 694 cases with single infection and 319 cases with coinfection.  
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